[go: up one dir, main page]

IS5510A - Efnasambönd sem verka gegn "picorna"-veirum og aðferðir til nota þeirra og smíða - Google Patents

Efnasambönd sem verka gegn "picorna"-veirum og aðferðir til nota þeirra og smíða

Info

Publication number
IS5510A
IS5510A IS5510A IS5510A IS5510A IS 5510 A IS5510 A IS 5510A IS 5510 A IS5510 A IS 5510A IS 5510 A IS5510 A IS 5510A IS 5510 A IS5510 A IS 5510A
Authority
IS
Iceland
Prior art keywords
picorna
viruses
compounds
construction
methods
Prior art date
Application number
IS5510A
Other languages
English (en)
Inventor
E. Webber Stephen
S. Dragovich Peter
J. Prins Thomas
S. Littlefield Ethel
T. Marakovits Joseph
E. Babine Robert
Original Assignee
Agouron Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharmaceuticals, Inc. filed Critical Agouron Pharmaceuticals, Inc.
Publication of IS5510A publication Critical patent/IS5510A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70One oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS5510A 1997-12-16 2000-05-25 Efnasambönd sem verka gegn "picorna"-veirum og aðferðir til nota þeirra og smíða IS5510A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/991,739 US5962487A (en) 1997-12-16 1997-12-16 Antipicornaviral compounds and methods for their use and preparation
PCT/US1998/026583 WO1999031122A1 (en) 1997-12-16 1998-12-15 Antipicornaviral compounds and methods for their use and preparation

Publications (1)

Publication Number Publication Date
IS5510A true IS5510A (is) 2000-05-25

Family

ID=25537509

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5510A IS5510A (is) 1997-12-16 2000-05-25 Efnasambönd sem verka gegn "picorna"-veirum og aðferðir til nota þeirra og smíða

Country Status (14)

Country Link
US (1) US5962487A (is)
EP (1) EP1037905A1 (is)
JP (1) JP2002508389A (is)
KR (1) KR20010033236A (is)
AU (1) AU762682B2 (is)
BR (1) BR9813651A (is)
CA (1) CA2312940A1 (is)
HU (1) HUP0100149A3 (is)
IL (1) IL136308A0 (is)
IS (1) IS5510A (is)
NO (1) NO20003067L (is)
NZ (1) NZ505034A (is)
PL (1) PL341435A1 (is)
WO (1) WO1999031122A1 (is)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214799B1 (en) * 1996-05-14 2001-04-10 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds and methods for their use and preparation
EP1073672B1 (en) * 1998-04-30 2003-08-27 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds, their preparation and use
EP1329457B1 (en) * 1998-04-30 2005-11-02 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds, their preparation and use
US6143079A (en) * 1998-11-19 2000-11-07 Asm America, Inc. Compact process chamber for improved process uniformity
US6369226B1 (en) 1999-06-21 2002-04-09 Agouron Pharmaceuticals, Inc. Substituted benzamide inhibitors of rhinovirus 3C protease
DK1206484T3 (da) * 1999-08-04 2005-01-24 Agouron Pharma Antipicornavirale forbindelser og sammensætninger, deres farmaceutiske anvendelser og materialer til deres syntese
US6355807B1 (en) * 1999-08-24 2002-03-12 Agouron Pharmaceuticals, Inc. Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
PE20010517A1 (es) * 1999-08-24 2001-05-16 Agouron Pharma Las rutas sinteticas eficientes para la preparacion de los inhibidores de la proteasa del rinovirus y los intermedios claves
US6774243B2 (en) 1999-08-24 2004-08-10 Agouron Pharmaceuticals, Inc. Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
PA8507801A1 (es) 1999-12-03 2002-08-26 Agouron Pharma Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis
WO2001064678A2 (en) * 2000-02-29 2001-09-07 Bristol-Myers Squibb Pharma Company Inhibitors of hepatitis c virus ns3 protease
PE20011277A1 (es) * 2000-04-14 2002-01-07 Agouron Pharma Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis
JP2004503533A (ja) * 2000-06-14 2004-02-05 アグロン・ファーマシュウティカルズ・インコーポレーテッド 抗ピコルナウイルス化合物及び組成物、その医薬的使用、並びにその合成のための物質
US6653295B2 (en) 2000-12-13 2003-11-25 Bristol-Myers Squibb Company Inhibitors of hepatitis C virus NS3 protease
US7064211B2 (en) * 2002-03-22 2006-06-20 Eisai Co., Ltd. Hemiasterlin derivatives and uses thereof
KR101208266B1 (ko) * 2002-03-22 2012-12-05 에자이 알앤드디 매니지먼트 가부시키가이샤 헤미아스텔린 유도체 및 이의 용도
AU2003238304A1 (en) * 2002-06-26 2004-01-19 Bristol-Myers Squibb Company Bicyclic pyrimidinones as coagulation cascade inhibitors
US20030125548A1 (en) * 2002-09-13 2003-07-03 Dorit Arad Molecules derived from mechanism based drug design
EP1704142A4 (en) * 2003-12-31 2008-08-20 Taigen Biotechnology Co Ltd PROTEASE INHIBITORS
US7462594B2 (en) * 2003-12-31 2008-12-09 Taigen Biotechnology Co., Ltd. Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases
ES2640814T3 (es) 2008-05-21 2017-11-06 Genesis Technologies Limited Inhibidores selectivos de caspasa y usos de los mismos
WO2010133000A1 (en) 2009-05-21 2010-11-25 New World Laboratories Inc. Selective caspase inhibitors and uses thereof
DK2697246T3 (en) 2011-04-15 2018-05-28 Genesis Tech Limited SELECTIVE CYSTEIN PROTEASE INHIBITORS AND USES THEREOF
WO2013049382A2 (en) 2011-09-27 2013-04-04 Kansas State University Research Foundation Broad-spectrum antivirals against 3c or 3c-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses
JP2013180983A (ja) * 2012-03-01 2013-09-12 Tokyo Univ Of Agriculture & Technology N置換アミド化合物の製造方法
WO2013166319A1 (en) 2012-05-02 2013-11-07 Kansas State University Research Foundation Macrocyclic and peptidomimetic compounds as broad-spectrum antivirals against 3c or 3c-like proteases of picornaviruses, caliciviruses and coronaviruses
WO2021188620A1 (en) * 2020-03-17 2021-09-23 Cocrystal Pharma Inc. Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
CN116648240B (zh) * 2021-01-22 2025-12-23 中国人民解放军军事科学院军事医学研究院 一种环肽类病毒蛋白酶抑制剂,其制备方法,及其在抗病毒药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06510986A (ja) * 1991-06-14 1994-12-08 カイロン コーポレイション ピコルナウイルスプロテアーゼのインヒビター
US5514778A (en) * 1993-07-01 1996-05-07 Eli Lilly And Company Anti-picornaviral agents
IL112759A0 (en) * 1994-02-25 1995-05-26 Khepri Pharmaceuticals Inc Novel cysteine protease inhibitors
IT1269511B (it) * 1994-05-17 1997-04-01 Univ Degli Studi Milano Derivati di acidi ammino-solfonici , loro impiego nella sintesi di pseudopeptidi e procedimento per la loro preparazione
DE69733137T2 (de) * 1996-05-14 2006-03-02 Agouron Pharmaceuticals, Inc., San Diego Inhibitoren von picornavirus 3c protease und verfahren zur herstellung und verwendung

Also Published As

Publication number Publication date
CA2312940A1 (en) 1999-06-24
EP1037905A1 (en) 2000-09-27
NZ505034A (en) 2003-07-25
US5962487A (en) 1999-10-05
BR9813651A (pt) 2000-10-03
KR20010033236A (ko) 2001-04-25
WO1999031122A1 (en) 1999-06-24
IL136308A0 (en) 2001-05-20
NO20003067L (no) 2000-08-15
AU762682B2 (en) 2003-07-03
JP2002508389A (ja) 2002-03-19
HUP0100149A2 (hu) 2001-06-28
WO1999031122A9 (en) 1999-09-30
HUP0100149A3 (en) 2001-12-28
PL341435A1 (en) 2001-04-09
AU1826299A (en) 1999-07-05
NO20003067D0 (no) 2000-06-15

Similar Documents

Publication Publication Date Title
IS5510A (is) Efnasambönd sem verka gegn "picorna"-veirum og aðferðir til nota þeirra og smíða
ID29434A (id) Kombinasi-kombinasi herbisida dan pengaman
DE69731559D1 (de) Gesichts- und atemschutzsystem
DE69719280D1 (de) Beatmungsgerät und dazugehöriges Gesichtsschutzstück
ID22889A (id) Komposisi kopolimer etilena dan penggunaannya
IS5341A (is) Samsett meðferð sem inniheldur atórvastatin og þrýstingslækkandi miðil
ID22957A (id) Senyawa dan penggunaannya
ID28846A (id) 2-fenilbenzimidazol dan 2_fenilindol, pembuatan dan penggunaanya
ID23575A (id) Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
ID29591A (id) Senyawa-senyawa kuinolina dan kuinoksalina
DE69836008D1 (de) Zusammensetzung und behandlungsmittel
DK1210943T3 (da) Ny anvendelse af budesonid og formoterol
DK1021410T3 (da) Prostaglandinagonister og deres anvendelse til behandling af knogletilstande
DE19983771T1 (de) Elektrochrome Gebilde und Strukturen
ID24196A (id) Komposisi dan penggunaan
NO984094D0 (no) Utladningsreaktor og anvendelse av samme
DK1112003T3 (da) Ny sammensætning og anvendelse
ID26402A (id) Amida-amida tersubstitusi yang baru, pembuatan dan penggunaannya
ID22009A (id) Metoda dan peralatan destilasi
ID28261A (id) Alat penghancur dan metoda penghancuran
IT1297664B1 (it) Valvola di sicurezza e di morosita'
ID29547A (id) Metoda dan komposisi untuk pencegahan dan pengobatan tuberkulosis
ID28368A (id) Tanda-tanda mikrosatelite tumbuhan dan metode terhadap penggunaannya
DE69916694D1 (de) 2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on
ID23258A (id) Penarik pemberian-menyilang dan metodenya